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A B S T R A C T
Purpose: To determine whether individuals with epilepsy who are depressed have different coping
reactions, such as increased use of disengagement-type coping reactions, compared to those who are not.
Methods: We surveyed 200 patients with epilepsy and obtained demographic and clinical information.
We used the Neurological Institute Disorders Depression Inventory for Epilepsy (NIDDI-E) to determine
those patients who had a major depression (NIDDI-E score >15) and administered the Quality of Life in
Epilepsy-10 Inventory (QOLIE-10), Beliefs About Medicines Questionnaire-Speciﬁc, Sheehan Disability
Scale, a screening question for health literacy (‘‘How conﬁdent are you ﬁlling out medical forms by
yourself?’’), and the Brief Coping with Problems Experienced (Brief-COPE). Using univariate analysis, we
determined those demographic and clinical variables that were associated with depression. We also
determined the coping reactions more frequently utilized by individuals with depression, and using
multivariate analysis, determined whether those coping reactions retained statistical signiﬁcance. We
performed subgroup analysis of depressed epilepsy patients to determine whether coping reactions they
preferentially utilized were associated with seizure frequency and quality of life.
Results: Seventy-one patients had a major depression while 128 did not. On univariate analysis, not
driving, not working, higher seizure frequency, experiencing convulsions, poorer quality of life, and
higher disability scores were signiﬁcantly associated with major depression. These individuals used
denial more often as a coping reaction. On multiple linear regression, the association between the use of
denial and being depressed retained statistical signiﬁcance. The mean denial coping scores were higher
among depressed patients with more frequent seizures. However, this did not reach statistical
signiﬁcance.
Conclusion: Individuals with epilepsy who have a major depression utilize denial more often as a coping
reaction. Realizing this is of value to caregivers as they help patients deal with their stressful situation.
This also provides additional impetus to more effectively and aggressively treatment depression in the
epilepsy population.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Epilepsy affects over one million people in the United States
(U.S.). Hauser and colleagues estimate an epilepsy point preva-
lence of up to 1% and a lifetime prevalence as well as a cumulative
incidence of up to 4% in the U.S.1,2 In a recent study, the Centers for
Disease Control, analyzing data from the 2010 National Health
Interview Survey, indicated that 1% of adults in the U.S. have
epilepsy.3* Corresponding author at: Department of Neurology, University of Florida HSC/
Jacksonville, 580 West Eighth Street, Tower One, Ninth Floor, Jacksonville, FL 32209,
USA. Tel.: +1 904 244 9190; fax: +1 904 244 9493.
E-mail address: ramon.bautista@jax.uﬂ.edu (R.E.D. Bautista).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.05.004Depression is one of the most prevalent psychiatric co-
morbidity encountered in patients with epilepsy.4,5 According to
Tellez-Zenteno and colleagues, there is a 17.4% lifetime prevalence
of a major depressive disorder in the epilepsy population
compared with 10.7% in the general population.6 In a survey of
over 4000 adults in the U.S. in 2004, 2.6% were informed by their
healthcare provider that they had a seizure disorder/epilepsy.
These individuals were 2.5 times more likely to have a self-
reported depression during the previous year and 2.3 times more
likely to have self-reported anxiety.7
Among the general population, the symptoms of depression are
vast, and include but are not limited to, appetite changes, anhedonia,
decreased energy, and suicidal ideations.8 Evidence demonstrating
that depression causes signiﬁcant disease burden is well-estab-
lished.9Across several medical conditions, the severity of co-existing
depression adversely affects morbidity and mortality, making itvier Ltd. All rights reserved.
R.E.D. Bautista, P.A. Erwin / Seizure 22 (2013) 686–691 687important then to treat both the primary disease as well as
coexisting depression.10,11
In the epilepsy population, coexisting depressive symptoms
leads not only to a substandard quality of life, but can also predict
poorer seizure control following medical intervention.12 In turn,
poor seizure control also predicts failure of other treatments.13
Coping strategies consist of behaviors, primarily management
and problem-solving techniques, that are designed to reduce
patient burden and are often implemented to manage stressful
situations.14 Various positive strategies may incorporate spiritual-
ity as well as emotional support from friends and family, the
utilization of distracters, or meditative techniques. On the other
hand, negative coping reactions may also be utilized, including
denial, self-blame, or even alcohol or drug use.
These various coping styles can also be categorized as being
either problem- or emotion-focused. Problem-focused techni-
ques, such as planning, are those that actively manage stressors. In
contrast, emotion-focused coping strategies, such as substance
abuse, are used in an attempt to avoid dealing directly
with stressful situations and often lead to patient denial and
avoidance.15,16
In other disease states such as heart failure, it has been shown
that maladaptive coping mechanisms such as denial and dis-
engagement are encountered more often among patients who are
depressed.17 What is not known is whether depression inﬂuences
coping strategies across the epilepsy population.
In this study, we surveyed epilepsy patients at a Level 4 epilepsy
center in Jacksonville, Florida, USA, to determine the coping
mechanisms utilized by those with depression, and compared
these with the coping reactions used by patients who were not
depressed. The coping mechanisms employed by patients with
epilepsy and depression have not been previously studied and
needs to be determined for several reasons. First, it is important to
know whether being depressed is associated with unhealthy
coping reactions; and if so, whether this may provide one
explanation for the poorer seizure control and inferior quality of
life encountered in this subset of epilepsy patients. Knowing the
coping reactions employed by epilepsy patients who are depressed
can also be of value to caregivers as they help patients deal with an
already stressful situation. Above all, realizing that depression is
associated with unhealthy coping reactions should provide
additional impetus to more aggressively and effectively manage
this often-encountered co-morbidity in the epilepsy population.
2. Methods
This study is an extension of a previous work that was detailed
in an earlier publication about the coping strategies of individuals
with epilepsy.18 Two hundred continuous individuals seen at the
Comprehensive Epilepsy Program-UFHSCJ outpatient clinics were
surveyed for this study. These patients were adults with a
diagnosis of localization-related (partial) epilepsy who had no
history of psychogenic, non-epileptic seizures. Patients were their
own primary caregivers and could complete the survey without
assistance.
The survey contained different demographic and clinical
variables that included age, gender, marital status, ethnicity
(Hispanic versus non-Hispanic), race, educational attainment,
annual household income, driving status, disability status,
employment status, age at seizure onset, seizure duration, seizure
frequency, presence of convulsions, occurrence of waking seizures,
seizure etiology, number of AEDs (antiepileptic drugs) they are
currently taking, and severity of side effects from their current AED
regimen. Various psychosocial instruments in the survey were also
utilized. These included the Neurological Institute Disorders
Depression Inventory for Epilepsy (NIDDI-E),19 Quality of Life inEpilepsy-10 Inventory (QOLIE-10),20 Beliefs About Medicines
Questionnaire-Speciﬁc (BMQ-S),21 Sheehan Disability Scale
(SDS),22 and a screening question for health literacy (‘‘How
conﬁdent are you ﬁlling out medical forms by yourself?’’; this
question was answered using a 5-point Likert scale with responses
ranging from ‘‘extremely’’ to ‘‘not at all’’). This health literacy
screening question was chosen because it correlated well with
overall Short Test of Functional Health Literacy Assessment
(STOHFLA) scores in detecting patients with limited health literacy
(AUROC 0.82).23 We also administered the Brief Coping with
Problems Experienced (Brief-COPE) Inventory and used disposi-
tion-type questions to assess the subjects’ coping strategies.24,25
For this study, we determined whether depression was
signiﬁcantly associated with particular coping strategies among
individuals with epilepsy. We deﬁned individuals with depression
as having a score >15 on the NIDDI-E as this has a sensitivity of
81%, speciﬁcity of 90%, and a positive predictive value of 62% for
diagnosing a major depression.19
The Institutional Review Board of the University of Florida
Health Sciences Center/Jacksonville (UFHSCJ) approved this study.
2.1. Statistical analysis
Statistical analysis was performed using SPSS 15.0TM at a 5%
level of signiﬁcance using a 2-tailed test. The null hypothesis was
that depressed and non-depressed did not signiﬁcantly differ
across the various demographic, clinical, and psychosocial
parameters measures, nor did they differ according to coping
strategies employed.
We enrolled 200 patients for the study. Based on this, the
categorical comparison of substrata (i.e. comparing coping
strategies of depressed and non-depressed subjects) had a power
of about 80% for detecting differences of a moderate effect size.
Comparisons and analysis using interval data also had sufﬁcient
power to detect operationally meaningful differences even within
substrata.
We ﬁrst determined whether depressed and non-depressed
patients differed from one another across various demographic,
clinical, and psychosocial, non-coping variables. We tested for the
equality of means for interval variables using ANOVA (transform-
ing certain data to satisfy the assumptions of ANOVA). We tested
ordinal variables using Mann Whitney and analyzed categorical
data with chi-square statistics. Adjusted standardized residuals
(ASR) were used as the post hoc comparison method.
We then determined whether depressed and non-depressed
individuals differed across the various coping strategies using
selected items from the Brief-COPE whose question-pairs had good
internal consistency based our the earlier study (Cronbach’s alpha
of at least 0.5). Included were the coping reactions of substance
abuse, religion, humor, instrumental support, acceptance, denial,
and emotional support, positive reframing, and planning. Active
coping, self-blame, behavioral disengagement, venting and self-
distraction were excluded from analysis due to poor internal
consistency. We also determined whether depressed and non-
depressed individuals differed on the two main coping clusters we
earlier identiﬁed using Principal Component Analysis: Factor 1
(engagement-type coping strategies) and Factor 2 (disengage-
ment-type coping strategies).17
Multiple linear regression (MLR) was performed to determine
whether coping strategies that distinguished depressed and non-
depressed patients on univariate analysis retained signiﬁcance in
the simultaneous context of the other signiﬁcant demographic,
clinical, and psychosocial variables.
We also performed subgroup analysis of depressed individuals
with epilepsy in order to determine whether coping strategies that
were preferentially utilized in this subgroup were associated with
R.E.D. Bautista, P.A. Erwin / Seizure 22 (2013) 686–691688important outcome measures such as seizure frequency and
quality of life.
3. Results
We detailed the demographic and clinical data for this study in
an earlier publication. In summary, the mean age of subjects was
41 years and 36% were males. More than half were Caucasians
while one-third were African-Americans. The majority had no
more than a high school education and more than half had an
annual household income of less than $10,000. Most respondents
did not operate a motor vehicle and more than half received
disability beneﬁts. The vast majority were not working.
The mean age of seizure onset was 23 years and average seizure
duration was 19 years. A quarter of subjects had less than one
seizure a year. The majority of subjects experienced generalized
tonic–clonic seizures and seizures while awake. More than half of
subjects did not have an identiﬁable cause for their seizures.
Subjects were on a varied number of seizure medications but more
than half did not experience any medication-related side effects.
The mean NIDDI-E and QOLIE-10 scores were 13.2 and 33.5
respectively. The mean BMQ-S score was 3.8 while average SDS
total score was 13.9. More than half the subjects did not experience
serious issues with health literacy.18
Of the 200 patients included in this study, one subject did not
complete the NIDDI-E and was excluded from further analysis.
Seventy-one subjects (37%) had a major depression (NIDDI-E score
of >15) while 128 did not. On univariate analysis, not driving, not
working, higher seizure frequency, having convulsive seizures,
higher (poorer) QOLIE-10 scores and higher (worse) SDS-scores
were signiﬁcantly associated with being depressed (Table 1).
When examining coping strategies, depressed individuals had
higher scores on denial compared to non-depressed patients
(Table 2).
Using multiple linear regression, the association between the
use of denial and being depressed remained statistically and
independently signiﬁcant in the simultaneous context of the other
demographic, clinical, and psychosocial variables found to be
signiﬁcant on univariate analysis (Table 3).
On subgroup analysis, the use of denial coping among
depressed patients with epilepsy was not statistically associated
with QOLIE-10 scores (p = 0.95; Pearson correlation, using
transformed data: SQRT  (45 minus QOLIE-10 score)). The mean
denial coping scores of patients who had daily and weekly seizures
were higher than those who had less frequent seizures (Fig. 1).
However, this did not reach statistical signiﬁcance (p = 0.44;
ANOVA). This analysis was limited as the number of patients
analyzed (n = 71) only had a power of 80% for detecting differences
of a large effect size.
4. Discussion
Coping describes the manner by which people deal with
stressful events and is often a result of multidimensional processes
determined by environmental conditions, cognitive abilities, and
personality dispositions.26 Our study investigated the coping
mechanisms employed by patients with epilepsy who also had
concomitant depression. Our study results reveal that more than a
third of our patients have a major depression (deﬁned as a NIDDI-E
scores >15) and that being depressed was associated with
increased use of denial coping. Also, being depressed was
associated with poorer quality of life, higher disability scores,
higher convulsions, higher frequency of seizures, not working, and
not driving. Among depressed epilepsy patients, those with more
frequent seizures had higher mean denial coping scores althoughthe association did not reach statistical signiﬁcance and may have
been limited by the small sample size.
Interestingly, variables such as epilepsy duration or the number
of AEDs used did not distinguish depressed from non-depressed
individuals.
Our results is one of many that emphasize the high prevalence
of psychiatric co-morbidities among individuals with epilepsy4–7
and also indicates that compared to non-depressed individuals,
those who are depressed place greater reliance on denial as a
coping strategy. This is likely of no surprise as denial has been
traditionally regarded as a maladaptive form of coping employed
by individuals across a variety of medical conditions in order to
reduce the tension and anxiety that occur with having an illness.27
Brajkovic and colleagues28 surveyed individuals with multiple
sclerosis to determine their coping styles and related these to
ongoing symptoms of depression and anxiety. The use of denial as
a coping reaction was associated with worsening depression and
anxiety as well as increased fatigue. A similar survey was
conducted by Burker and colleagues29 on a group of patients
who were being evaluated for heart transplant. Of all coping
strategies, denial had the strongest association with depression
and emotional distress. Among older individuals with heart failure,
it was shown that the use of maladaptive coping reactions such as
denial, self-blame, and self-distraction were associated with poor
quality of life and the presence of depressed symptoms.30
The impact of the use of denial as a coping mechanism goes
beyond affective issues and may directly impact care. In a study of
homosexual females, Vyavaharkar and colleagues31 determined
that individuals with coping mechanisms that focused on
avoidance and denial also had poorer medication adherence.
The higher mean denial coping scores seen among our
depressed epilepsy patients who have more frequent seizures is
somewhat intriguing and raises the question of whether the use of
this maladaptive strategy is one of the key reasons for the link
between being depressed and poor clinical outcomes.4,5 Future
studies with larger sample sizes will be necessary to conﬁrm
whether this association is statistically signiﬁcant.
Understanding the coping reactions employed by individuals
with epilepsy is important and should lead to the development of
treatment protocols designed to help improve their quality of life
as well as their ability to deal with their disorder. An example of
this can be found in a study by Carrico and colleagues32 that
implemented a stress management program for HIV+ homosexual
males receiving highly active antiretroviral therapy (HAART). One
intervention arm consisted of a 10-week cognitive behavioral
stress training with medication adherence training (CBSM+MAT)
while the other arm consisted only of medication adherence
training. Though no changes in self-reported adherence was seen
among the two groups, the authors demonstrated that patients in
the CBSM+MAT arm had signiﬁcantly depressed mood and
decreased use of denial coping during the intervention period.
Using path analysis, an initial high reliance on denial coping at
baseline was associated with a signiﬁcant reduction in depressed
mood after the 10-week intervention.
Our study has several limitations. Our research was conducted
in a primarily urban region in the southeast United States that
caters to an inner city population in the Southeastern United
States. Thus, it may be difﬁcult to replicate our study ﬁndings in
other epilepsy populations with a different demographic proﬁle.
Secondly, the data collected were from subjects who consented to
participating in the study and were required to self-report their
information while answering the questionnaire. Patients enrolled
into the study had to be able to care for themselves and answer the
questionnaire without assistance. These conditions allow for the
possibility of both sampling and responder bias based on the
patients’ own perception of the questions and perhaps even their
Table 1
Characteristics of depressed and non-depressed subjects.a
Non depressed Depressed p-Value
Number of subjects 128 71
Age, mean (SD) 42.5 (15.9) 42.7 (12.6) 0.92b
Males, n (%) 42 (32.8) 18 (25.4) 0.27c
Hispanic, n (%) 6 (4.7) 7 (8.5) 0.29c
Race 0.62c
Caucasian, n (%) 71 (55.5) 42 (59.2)
African-American, n (%) 47 (36.7) 23 (32.4)
Others, n (%) 10 (7.8) 6 (8.4)
Marital status 0.89c
Single, n (%) 52 (40.6) 29 (40.8)
Married, n (%) 54 (42.2) 28 (39.4)
Divorced, n (%) 17 (13.3) 12 (16.9)
Widowed, n (%) 5 (3.9) 2 (2.8)
Highest educational level 0.06d
Less than high school, n (%) 26 (20.3) 21 (29.6)
High school, no college, n (%) 52 (40.6) 29 (40.8)
Some college/associates degree, n (%) 33 (25.8) 18 (25.4)
Bachelor’s/technical degree, n (%) 14 (10.9) 2 (2.8)
Graduate/post-graduate, n (%) 3 (2.3) 1 (1.4)
Annual household income 0.1d
Less than $10,000, n (%) 66 (51.6) 44 (62)
Between $10,000 and $50,000, n (%) 37 (28.9) 20 (28.2)
Between $50,000 and $100,000, n (%) 21 (16.4) 5 (7)
More than $100,000, n (%) 4 (3.1) 2 (2.8)
Drives a motor vehicle, yes, n (%) 43 (33.6) 11 (15.5) <0.01c
Receives disability beneﬁts, yes, n (%) 66 (51.6) 38 (53.5) 0.79c
Work status <0.01d
Works full-time, n (%) (ASR) 19 (14.8) (2.6) 2 (2.8) (2.6)
Works part-time, n (%) (ASR) 13 (10.2) (1.5) 3 (4.2) (1.5)
Unemployed, n (%) (ASR) 96 (75) (3.1) 66 (93) (3.1)
Age of seizure onset in years, mean (SD) 22.9 (17.9) 24.9 (15) 0.35b,e
Seizure duration in years, mean (SD) 20.2 (16.8) 17.9 (15.3) 0.35b
Seizure frequency <0.01d
Daily, n (%) (ASR) 6 (4.7) (1.1) 6 (8.5) (1.1)
Less than daily but more than once a week, n (%) (ASR) 10 (7.8) (3.2) 17 (23.9) (3.2)
Less than weekly but at least once a month, n (%) (ASR) 28 (21.9) (1.4) 22 (31) (1.4)
Less than monthly but at least once a year, n (%) (ASR) 37 (28.9) (0.3) 19 (26.8) (0.3)
Less than once a year, n (%) (ASR) 47 (36.7) (4.1) 7 (9.9) (4.1)
Experiences convulsions, n (%) 66 (51.6) 48 (67.6) 0.03c
Has seizures while awake, n (%) 91 (71.7) 58 (81.7) 0.1c
Etiology 0.72c
Head trauma, n (%) 29 (22.7) 12 (16.9)
Stroke, n (%) 5 (3.9) 1 (1.4)
Brain tumor, n (%) 6 (4.7) 4 (5.6)
Other, n (%) 24 (18.8) 15 (21.1)
Unknown, n (%) 64 (50) 39 (54.9)
Number of antiepileptic drugs (AED) 0.66d
No AED, n (%) 4 (3.1) 0
One AED, n (%) 34 (26.6) 21 (29.6)
Two AEDs, n (%) 37 (28.9) 18 (25.4)
More than two AEDs, n (%) 53 (41.4) 32 (45.1)
Side effects from current AED regimen 0.052d
None, n (%) 70 (54.7) 34 (47.9)
Minor inconvenience, n (%) 50 (39.1) 19 (26.8)
Major problem, n (%) 8 (6.3) 18 (25.4)
QOLIE-10f scores, mean (SD) 22.1 (6.2) 32 (6.9) <0.01b,g
BMQ-Sh score, mean (SD) 4.2 (5.6) 3.3 (5.4) 0.28b
SDSi score, mean (SD) 9.6 (8.4) 19.1 (8.9) <0.01b
‘‘How conﬁdent are you ﬁlling out medical forms by yourself?’’ 0.16d
Extremely, n (%) 42 (32.8) 18 (25.4)
Quite a bit, n (%) 27 (21.1) 9 (12.7)
Somewhat, n (%) 21 (16.4) 22 (31)
A little bit, n (%) 17 (13.3) 7 (9.9)
Not at all, n (%) 21 (16.4) 15 (21.1)
ASR, adjusted standardized residuals.




e Transformed data: SQRT  seizure onset (in years).
f Quality of Life in Epilepsy-10.
g Transformed data: SQRT  (45 minus QOLIE-10 score).
h Beliefs About Medicines Questionnaire-Speciﬁc (Necessity minus Concerns).
i Sheehan Disability Scale.
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Table 2
Comparison of coping strategies of depressed and non-depressed patients.a
Coping strategy Non depressed Depressed p-Valueb
Substance abuse, mean (SD) 1.2 (0.6) 1.1 (0.4) 0.27
Religion, mean (SD) 2.9 (1.2) 2.8 (1.1) 0.57
Humor, mean (SD) 1.9 (1) 1.7 (1) 0.32
Instrumental support, mean (SD) 2.7 (1) 2.7 (1) 0.57
Denial, mean (SD) 1.5 (0.7) 1.9 (1) <0.01
Acceptance, mean (SD) 3.3 (0.9) 3.2 (0.8) 0.25
Emotional support, mean (SD) 2.7 (1) 2.9 (1) 0.32
Positive reframing, mean (SD) 2.6 (1) 2.5 (1) 0.25
Planning, mean (SD) 2.4 (0.9) 2.6 (1) 0.22
Factor 1c, mean (SD) 2.8 (0.7) 2.8 (0.7) 0.96
Factor 2d, mean (SD) 1.5 (0.6) 1.6 (0.5) 0.36
a Missing data not included in analysis; based on Neurological Institute Disorders
Depression Inventory for Epilepsy (NIDDI-E). Scores >15 indicate a major
depression.
b ANOVA.
c Factor 1 consists of religion, instrumental support, acceptance, emotional
support, positive reframing, and planning.
d Factor 2 consists of substance abuse, humor, and denial.
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Fig. 1. The association between seizure frequency and use of denial coping in
epilepsy patients who are depressed. Although the mean denial coping scores were
higher among patients with daily and weekly seizures, this did not reach statistical
signiﬁcance (p = 0.44; ANOVA) and may have been limited by the small sample size
(n = 71).
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evaluating our patients’ coping strategies was the Brief-COPE.
Thus, the coping reactions assessed in this study were limited to
those measured by this tool.
Future researches are necessary in order to broaden our
understanding of the coping strategies employed by individuals
with epilepsy and to determine how this impacts treatment
outcomes. This would include comparing the coping strategies of
depressed individuals with epilepsy to those who do not have
epilepsy but are likewise depressed. This would allow us to
determine whether the coping reaction is a function of having
epilepsy, or determined primarily by the subject’s depressed state.
Another research should look at the effects treatment regimens for
depressed individuals with epilepsy (i.e. pharmacologic versus
behavioral therapy) may have on their coping strategies. Deter-
mining whether epilepsy type inﬂuences coping strategies is
another interesting ﬁeld of research. Lastly, other variables that
could have inﬂuenced coping techniques, such as medication
adherence, should be examined in future studies.
The results of this study highlight an important, and previously
unknown, characteristic of epilepsy patients who simultaneously
experience seizures while attempting to manage their depression.
Future studies are needed in order to conﬁrm whether the use of
maladaptive coping strategies in these patients adversely affect
treatment outcomes. On an individual level, understanding how
patients cope with their condition provides some assistance to loveTable 3
Multiple linear regression of variables associated with denial.a
Variable B Std. error p-Value 95% Conﬁdence
interval
Lower Higher
Constant 1.83 0.47 <0.01 0.9 2.75
NIDDI-Eb 0.42 0.14 <0.01 0.14 0.7
Driving 0.06 0.03 0.08 0.006 0.12
Work status 0.09 0.1 0.4 0.29 0.12
Seizure frequency 0.1 0.06 0.1 0.21 0.17
GTC seizures 0.01 0.02 0.63 0.04 0.06
QOLIE-10c scores 0.08 0.07 0.27 0.002 0.03
SDSd scores 0.02 0.01 0.08 0.002 0.03
a Variables with p  0.05 using univariate analysis were included in analysis.
b Neurological Institute Disorders Depression Inventory for Epilepsy. Scores >15
indicate a major depression.
c Quality of Life in Epilepsy-10 Inventory; transformed data: SQRT  (45 minus
QOLIE-10 score).
d Sheehan Disability Scale scores.ones and caregivers as they help patients deal with their condition
on a daily basis. Above all, this study provides additional impetus
on the need to more effectively identify and aggressively treat
depression among individuals with epilepsy.
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